Action potential and calcium dependence of tonic somatodendritic dopamine release in the Substantia Nigra pars compacta

Despite the importance of somatodendritic dopamine (DA) release in the Substantia Nigra pars compacta (SNc), its mechanism remains poorly understood. Using a novel approach combining fast‐scan controlled‐adsorption voltammetry (FSCAV) and single‐unit electrophysiology, we have investigated the mechanism of somatodendritic release by directly correlating basal (non‐stimulated) extracellular DA concentration ([DA]out), with pharmacologically‐induced changes of firing of nigral dopaminergic neurons in rat brain slices. FSCAV measurements indicated that basal [DA]out in the SNc was 40.7 ± 2.0 nM (at 34 ± 0.5°C), which was enhanced by amphetamine, cocaine, and L‐DOPA, and reduced by VMAT2 inhibitor, Ro4‐1284. Complete inhibition of firing by TTX decreased basal [DA]out, but this reduction was smaller than the effect of D2 receptor agonist, quinpirole. Despite similar effects on neuronal firing, the larger decrease in [DA]out evoked by quinpirole was attributed to cell membrane hyperpolarization and greater reduction in cytosolic free Ca2+ ([Ca2+]in). Decreasing extracellular Ca2+ also reduced basal [DA]out, despite increasing firing frequency. Furthermore, inhibiting L‐type Ca2+ channels decreased basal [DA]out, although specific Cav1.3 channel inhibition did not affect firing rate. Inhibition of sarcoplasmic/endoplasmic reticulum Ca2+‐ATPase (SERCA) also decreased [DA]out, demonstrating the importance of intracellular Ca2+ stores for somatodendritic release. Finally, in vivo FSCAV measurements showed that basal [DA]out in the SNc was 79.8 ± 10.9 nM in urethane‐anesthetized rats, which was enhanced by amphetamine. Overall, our findings indicate that although tonic somatodendritic DA release is largely independent of action potentials, basal [DA]out is strongly regulated by voltage‐dependent Ca2+ influx and release of intracellular Ca2+.

[1]  H. Sitte,et al.  An unsuspected role for organic cation transporter 3 in the actions of amphetamine , 2018, Neuropsychopharmacology.

[2]  John T. Williams,et al.  The Evolving Understanding of Dopamine Neurons in the Substantia Nigra and Ventral Tegmental Area. , 2018, Annual review of physiology.

[3]  D. Surmeier,et al.  Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease , 2017, Experimental Neurology.

[4]  B. Liss,et al.  Lower Affinity of Isradipine for L-Type Ca2+ Channels during Substantia Nigra Dopamine Neuron-Like Activity: Implications for Neuroprotection in Parkinson's Disease , 2017, The Journal of Neuroscience.

[5]  H. Yin The Basal Ganglia in Action , 2017, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[6]  John T. Williams,et al.  Cholinergic Interneurons Underlie Spontaneous Dopamine Release in Nucleus Accumbens , 2017, The Journal of Neuroscience.

[7]  Peter S. Freestone,et al.  Paradoxical lower sensitivity of Locus Coeruleus than Substantia Nigra pars compacta neurons to acute actions of rotenone , 2017, Experimental Neurology.

[8]  M. Kennard,et al.  Measuring benefits of protected area management: trends across realms and research gaps for freshwater systems , 2015, Philosophical Transactions of the Royal Society B: Biological Sciences.

[9]  J. Lipski,et al.  A novel electrochemical approach for prolonged measurement of absolute levels of extracellular dopamine in brain slices. , 2015, ACS Chemical Neuroscience.

[10]  Garret D Stuber,et al.  Optogenetic versus electrical stimulation of dopamine terminals in the nucleus accumbens reveals local modulation of presynaptic release , 2015, Journal of neurochemistry.

[11]  Nerea Llamosas,et al.  Depression of Serotonin Synaptic Transmission by the Dopamine Precursor L-DOPA. , 2015, Cell reports.

[12]  M. Rice,et al.  Somatodendritic dopamine release: recent mechanistic insights , 2015, Philosophical Transactions of the Royal Society B: Biological Sciences.

[13]  Michael L Heien,et al.  Biocompatible PEDOT:Nafion composite electrode coatings for selective detection of neurotransmitters in vivo. , 2015, Analytical chemistry.

[14]  M. Heien,et al.  The coaction of tonic and phasic dopamine dynamics. , 2015, Chemical communications.

[15]  E. Kavalali The mechanisms and functions of spontaneous neurotransmitter release , 2014, Nature Reviews Neuroscience.

[16]  C. P. Ford The role of D2-autoreceptors in regulating dopamine neuron activity and transmission , 2014, Neuroscience.

[17]  Michael L Heien,et al.  Fast-scan controlled-adsorption voltammetry for the quantification of absolute concentrations and adsorption dynamics. , 2013, Langmuir : the ACS journal of surfaces and colloids.

[18]  P. Tuite Phase II safety, tolerability, and dose selection study of isradipine as a potential disease‐modifying intervention in early Parkinson's disease (STEADY‐PD) , 2013, Movement disorders : official journal of the Movement Disorder Society.

[19]  John T. Williams,et al.  Spontaneous Inhibitory Synaptic Currents Mediated by a G Protein-Coupled Receptor , 2013, Neuron.

[20]  Lesley A. Colgan,et al.  Action Potential-Independent and Pharmacologically Unique Vesicular Serotonin Release from Dendrites , 2012, The Journal of Neuroscience.

[21]  M. Rice,et al.  Differential Calcium Dependence of Axonal Versus Somatodendritic Dopamine Release, with Characteristics of Both in the Ventral Tegmental Area , 2011, Front. Syst. Neurosci..

[22]  L. Trudeau,et al.  Somatodendritic Dopamine Release Requires Synaptotagmin 4 and 7 and the Participation of Voltage-gated Calcium Channels* , 2011, The Journal of Biological Chemistry.

[23]  Pavel Takmakov,et al.  Higher sensitivity dopamine measurements with faster-scan cyclic voltammetry. , 2011, Analytical chemistry.

[24]  E. Kavalali,et al.  Differential regulation of spontaneous and evoked neurotransmitter release at central synapses , 2011, Current Opinion in Neurobiology.

[25]  Paul T. Schumacker,et al.  Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1 , 2010, Nature.

[26]  M. Rice,et al.  Immunocytochemical identification of proteins involved in dopamine release from the somatodendritic compartment of nigral dopaminergic neurons , 2009, Neuroscience.

[27]  D. James Surmeier,et al.  Robust Pacemaking in Substantia Nigra Dopaminergic Neurons , 2009, The Journal of Neuroscience.

[28]  F. Zhou,et al.  An Ultra-Short Dopamine Pathway Regulates Basal Ganglia Output , 2009, The Journal of Neuroscience.

[29]  M. Rice,et al.  Mobilization of Calcium from Intracellular Stores Facilitates Somatodendritic Dopamine Release , 2009, The Journal of Neuroscience.

[30]  J. Dostrovsky,et al.  Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients. , 2009, Brain : a journal of neurology.

[31]  C. Thaller,et al.  Syntaxin 3b is a t‐SNARE specific for ribbon synapses of the retina , 2008, The Journal of comparative neurology.

[32]  Sungkwon Chung,et al.  Voltage-operated Ca2+ channels regulate dopamine release from somata of dopamine neurons in the substantia nigra pars compacta. , 2008, Biochemical and biophysical research communications.

[33]  S. Cragg,et al.  Dopamine spillover after quantal release: Rethinking dopamine transmission in the nigrostriatal pathway , 2008, Brain Research Reviews.

[34]  Bertram Krumm,et al.  Cocaine‐induced dopamine overflow within the nucleus accumbens measured by in vivo microdialysis: A meta‐analysis , 2008, Synapse.

[35]  R. Heidelberger Mechanisms of tonic, graded release: lessons from the vertebrate photoreceptor , 2007, The Journal of physiology.

[36]  E. Schuman,et al.  Postsynaptic Decoding of Neural Activity: eEF2 as a Biochemical Sensor Coupling Miniature Synaptic Transmission to Local Protein Synthesis , 2007, Neuron.

[37]  E. Kiyatkin,et al.  Dopamine action in the substantia nigra pars reticulata: iontophoretic studies in awake, unrestrained rats , 2006, The European journal of neuroscience.

[38]  L. Trudeau,et al.  Basal somatodendritic dopamine release requires snare proteins , 2006, Journal of neurochemistry.

[39]  M. Rice,et al.  Limited regulation of somatodendritic dopamine release by voltage‐sensitive Ca2+ channels contrasted with strong regulation of axonal dopamine release , 2006, Journal of neurochemistry.

[40]  G. Bernardi,et al.  Voltage-gated calcium channels mediate intracellular calcium increase in weaver dopaminergic neurons during stimulation of D2 and GABAB receptors. , 2004, Journal of neurophysiology.

[41]  J. Campusano,et al.  Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain , 2004, Brain Research Reviews.

[42]  Y. Michotte,et al.  In vivo characterization of somatodendritic dopamine release in the substantia nigra of 6‐hydroxydopamine‐lesioned rats , 2004, Journal of neurochemistry.

[43]  D. Grandy,et al.  Vesicular Dopamine Release Elicits an Inhibitory Postsynaptic Current in Midbrain Dopamine Neurons , 2004, Neuron.

[44]  J. B. Justice,et al.  Microdialysis of dopamine interpreted with quantitative model incorporating probe implantation trauma , 2003, Journal of neurochemistry.

[45]  G. Gerhardt,et al.  Chloral hydrate and ethanol, but not urethane, alter the clearance of exogenous dopamine recorded by chronoamperometry in striatum of unrestrained rats , 2003, Neuroscience Letters.

[46]  E. Abercrombie,et al.  Differential regulation of somatodendritic and nerve terminal dopamine release by serotonergic innervation of substantia nigra , 2003, Journal of neurochemistry.

[47]  F. Bergquist,et al.  Evidence for different exocytosis pathways in dendritic and terminal dopamine release in vivo , 2002, Brain Research.

[48]  M. Rice,et al.  Novel Ca2+ Dependence and Time Course of Somatodendritic Dopamine Release: Substantia Nigra versus Striatum , 2001, The Journal of Neuroscience.

[49]  B. Falkenburger,et al.  Dendrodendritic Inhibition Through Reversal of Dopamine Transport , 2001, Science.

[50]  C. Nicholson,et al.  Amphetamine Distorts Stimulation-Dependent Dopamine Overflow: Effects on D2 Autoreceptors, Transporters, and Synaptic Vesicle Stores , 2001, The Journal of Neuroscience.

[51]  C. Kruse,et al.  In vitro modulation of the firing rate of dopamine neurons in the rat substantia nigra pars compacta and the ventral tegmental area by antipsychotic drugs , 2001, Neuropharmacology.

[52]  J. Salamone,et al.  Substantia nigra pars reticulata is a highly potent site of action for the behavioral effects of the D1 antagonist SCH 23390 in the rat , 2001, Psychopharmacology.

[53]  G. Gerhardt,et al.  Differences in pharmacological properties of dopamine release between the substantia nigra and striatum: an in vivo electrochemical study. , 1999, The Journal of pharmacology and experimental therapeutics.

[54]  G. Gerhardt,et al.  Voltage-dependency of the dopamine transporter in the rat substantia nigra , 1999, Neuroscience Letters.

[55]  G. Gerhardt,et al.  Dopamine transporter activity in the substantia nigra and striatum assessed by high-speed chronoamperometric recordings in brain slices. , 1998, The Journal of pharmacology and experimental therapeutics.

[56]  M. Rice,et al.  Dependence of dopamine calibration factors on media Ca2+ and Mg2+ at carbon-fiber microelectrodes used with fast-scan cyclic voltammetry , 1998, Journal of Neuroscience Methods.

[57]  A. Marty,et al.  Extrasynaptic Vesicular Transmitter Release from the Somata of Substantia Nigra Neurons in Rat Midbrain Slices , 1998, The Journal of Neuroscience.

[58]  G. Radnikow,et al.  Dopamine D1 Receptors Facilitate GABAASynaptic Currents in the Rat Substantia Nigra Pars Reticulata , 1998, The Journal of Neuroscience.

[59]  R. Wightman,et al.  Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter , 1998, The Journal of Neuroscience.

[60]  S. Cragg,et al.  Dopamine is released spontaneously from developing midbrain neurons in organotypic culture , 1998, Neuroscience.

[61]  G. Gerhardt,et al.  In VivoMicrodialysis Studies of Somatodendritic Dopamine Release in the Rat Substantia Nigra: Effects of Unilateral 6-OHDA Lesions and GDNF , 1997, Experimental Neurology.

[62]  H. Nissbrandt,et al.  Effects of drugs interfering with sodium channels and calcium channels on the release of endogenous dopamine from superfused substantia nigra slices , 1997, Synapse.

[63]  S. Cragg,et al.  Differential Autoreceptor Control of Somatodendritic and Axon Terminal Dopamine Release in Substantia Nigra, Ventral Tegmental Area, and Striatum , 1997, The Journal of Neuroscience.

[64]  S. Cragg,et al.  Characteristics of electrically evoked somatodendritic dopamine release in substantia nigra and ventral tegmental area in vitro. , 1997, Journal of neurophysiology.

[65]  S. Cragg,et al.  Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area, and striatum. , 1997, Journal of neurophysiology.

[66]  V. Pickel,et al.  Ultrastructural Localization of the Vesicular Monoamine Transporter-2 in Midbrain Dopaminergic Neurons: Potential Sites for Somatodendritic Storage and Release of Dopamine , 1996, The Journal of Neuroscience.

[67]  P. Calabresi,et al.  Electrophysiological effects of monoamine oxidase inhibition on rat midbrain dopaminergic neurones: an in vitro study , 1996, British journal of pharmacology.

[68]  E. Abercrombie,et al.  Biochemistry of Somatodendritic Dopamine Release in Substantia Nigra: An In Vivo Comparison with Striatal Dopamine Release , 1995, Journal of neurochemistry.

[69]  A. D. Smith,et al.  Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: Light and electron microscopy , 1995, Neuroscience.

[70]  S. Hernández,et al.  Activation of subthalamic neurons produces NMDA receptor-mediated dendritic dopamine release in substantia nigra pars reticulata: a microdialysis study in the rat , 1994, Brain Research.

[71]  S. Sesack,et al.  Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[72]  I. Engberg,et al.  Nifedipine‐ and omega‐conotoxin‐sensitive Ca2+ conductances in guinea‐pig substantia nigra pars compacta neurones. , 1993, The Journal of physiology.

[73]  D. Sulzer,et al.  Amphetamine and Other Weak Bases Act to Promote Reverse Transport of Dopamine in Ventral Midbrain Neurons , 1993, Journal of neurochemistry.

[74]  G. Damsma,et al.  Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[75]  G. Yancopoulos,et al.  BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra , 1991, Nature.

[76]  A. Grace,et al.  Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[77]  L. Chiodo Dopamine-containing neurons in the mammalian central nervous system: Electrophysiology and pharmacology , 1988, Neuroscience & Biobehavioral Reviews.

[78]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[79]  J. Lipski,et al.  Antidromic activation of neurones as an analytic tool in the study of the central nervous system , 1981, Journal of Neuroscience Methods.

[80]  G. Aghajanian,et al.  Antidromic identification of dopaminergic and other output neurons of the rat substantia nigra , 1978, Brain Research.

[81]  T. Jessell,et al.  Release of dopamine from dendrites in rat substantia nigra , 1976, Nature.

[82]  R. Roth,et al.  Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. , 1973, The Journal of pharmacology and experimental therapeutics.

[83]  A. Crocker The Regulation of Motor Control: An Evaluation of the Role of Dopamine Receptors in the Substantia Nigra , 1997, Reviews in the neurosciences.

[84]  M. Zigmond,et al.  Reactive dopamine metabolites and neurotoxicity: implications for Parkinson's disease. , 1996, Advances in experimental medicine and biology.